These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20419835)

  • 1. Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement.
    Metzger R; Bollschweiler E; Drebber U; Mönig SP; Schröder W; Alakus H; Kocher M; Baldus SE; Hölscher AH
    World J Gastroenterol; 2010 Apr; 16(16):1986-92. PubMed ID: 20419835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer.
    D'Journo XB; Avaro JP; Michelet P; Trousse D; Tasei AM; Dahan L; Doddoli C; Guidicelli R; Fuentes P; Seitz JF; Thomas P
    J Thorac Oncol; 2009 Apr; 4(4):534-9. PubMed ID: 19347985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy.
    Lagarde SM; Navidi M; Gisbertz SS; van Laarhoven HW; Sumpter K; Meijer SL; Disep B; Immanuel A; Griffin SM; van Berge Henegouwen MI
    Br J Surg; 2016 Nov; 103(12):1658-1664. PubMed ID: 27696382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.
    Depypere LP; Moons J; Mariette C; D'Journo XB; Thomas PA; Hölscher AH; Bollschweiler E; van Berge-Henegouwen MI; Van Lanschot JJB; Lerut TEMR; Nafteux PR
    Ann Surg; 2018 Dec; 268(6):1000-1007. PubMed ID: 28742714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
    Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
    Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.
    Nafteux PR; Lerut AM; Moons J; Hölscher AH; Bollschweiler E; van Berge Henegouwen MI; Lagarde SM; van Lanschot JJ; Messager M; Mariette C; D'Journo XB; Thomas PA; De Leyn PR
    Ann Surg; 2015 Nov; 262(5):809-15; discussion 815-6. PubMed ID: 26583670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; de Boer DJ; Busch OR; Obertop H; van Lanschot JJ
    Am J Surg Pathol; 2006 Feb; 30(2):171-6. PubMed ID: 16434890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracapsular lymph node involvement is a robust survival predictor in esophageal cancer patients: A pooled analysis.
    Chen D; Mao Y; Zheng Y; Wen J; Song P; Xue Y; Wang W; Sang Y; Chen Y; Dai C
    Eur J Surg Oncol; 2021 Aug; 47(8):1875-1882. PubMed ID: 33795171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: Implications for staging and adjuvant treatment strategies.
    Brabender J; Bollschweiler E; Hölscher AH; Strobel K; Gutschow C; Prenzel K; Grimminger P; Drebber U; Schröder W; Metzger R; Vallböhmer D
    Oncol Lett; 2012 Apr; 3(4):825-830. PubMed ID: 22741001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
    Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
    Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer.
    Wind J; ten Kate FJ; Kiewiet JJ; Lagarde SM; Slors JF; van Lanschot JJ; Bemelman WA
    Eur J Surg Oncol; 2008 Apr; 34(4):390-6. PubMed ID: 17614246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
    Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
    Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
    Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.